ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Spinraza 12mg/5ml, Injektionslösung zur intrathekalen Injektion - 5 ml
66495001 PPBiogen Switzerland AG
Spinraza 12mg/5ml, Injektionslösung zur intrathekalen Injektion20.09.2017
  20.09.2017
Other Drugs for Disorders Of The Musculo-Skeletal System (M09AX) 
WHO-DDD 
10000.5 ml
01.99. 
A  
Yes 
IPCI
70024.60Yes
    
10 %72153.05
  
7680664950014Transplantat: Gentherapieprodukt
7211585 
Composition
nusinersenum 12 mg ut nusinersenum natricum 12.6 mg, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, kalii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp. natrium max. 18.17 mg et kalium 0.59 mg.
Packungsbestandteile
Injektionslösung zur intrathekalen Injektion 
  
 
Active AgentDose
Nusinersenum12mg / 5ml
BAG: Active AgentDose
Nusinersenum12 mg
 
Inactive agents
Acidum Hydrochloridum ad Ph
Calcii Chloridum Dihydricum
Disodium Phosphate
Kalii Chloridum
Magnesium Chloride Hexahydrate
Sodium Chloride
Sodium Dihydrogenophosphate Dihydrate
Natrii Hydroxidum ad Ph
 
Source
Data was imported : 05.03.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home